The association between calcium channel blocker use and prostate cancer outcome-Reference-Cited by-同舟云学术

The association between calcium channel blocker use and prostate cancer outcome

Published:2012-12-31 Issue:8 Volume:73 Page:865-872
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Poch Michael A.¹,Mehedint Diana¹,Green Dawn J.¹,Payne‐Ondracek Rochelle²,Fontham Elizabeth T.H.³,Bensen Jeannette T.⁴,Attwood Kristopher⁵,Wilding Gregory E.⁵,Guru Khurshid A.¹,Underwood Willie¹,Mohler James L.¹,Heemers Hannelore V.¹

Affiliation:

1. Department of Urology, Roswell Park Cancer Institute, Buffalo, New York

2. Department of Cancer Prevention and Population Sciences, Roswell Park Cancer Institute, Buffalo, New York

3. Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

4. Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

5. Department of Biostatistics, Roswell Park Cancer Institute, Buffalo, New York

Funder

Roswell Park Alliance Foundation

NCI

Department of Defense (DoD) Prostate Cancer Research Program

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.22632

Reference20 articles.

1. Hypertension, Heart Rate, Use of Antihypertensives, and Incident Prostate Cancer

2. Blood pressure and risk of prostate cancer: cohort Norway (CONOR)

3. The renin–angiotensin system and cancer: old dog, new tricks

4. Inverse Association between Prostate Cancer and the Use of Calcium Channel Blockers

5. Association between captopril, other antihypertensive drugs and risk of prostate cancer

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of antihypertensive medicines in prostate cancer: a systematic review;BMC Cancer;2024-04-29

2. Concomitant antihypertensive medication and outcome of patients with metastatic castration‐resistant prostate cancer receiving enzalutamide or abiraterone acetate;Cancer Medicine;2024-01

3. CACNA1D overexpression and voltage-gated calcium channels in prostate cancer during androgen deprivation;Scientific Reports;2023-03-22

4. The risk of second primary malignancies in colorectal cancer patients using calcium channel blockers;Scientific Reports;2023-03-01

5. Voltage-Gated Calcium Channels as Key Regulators of Cancer Progression;Voltage-Gated Calcium Channels;2022